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Background:  Cross-sectional measurement of epicardial fat volume (EFV) has been associated with coronary calcium score (CCS) and 
cardiovascular events. Our objective was to evaluate whether index and serial change in EFV and thoracic fat volume (TFV) relate to incident 
coronary calcium (incCC). 
Methods:  From a cohort of 1248 patients who underwent 2 cardiac CT scans 4 years apart to measure CCS, we compared 106 patients (mean 
age 57 years, 47% women, 62% with estimated 10-year cardiovascular event risk of < 10%) in whom CCS increased from 0 ( “incCC+”) to 106 
gender and age-decile-matched controls in whom CCS remained 0 ( “incCC-“). CT data was used to quantify EFV and TFV. EFV was calculated after a 
blinded expert defined the pericardial contour, within which fat voxels were automatically identified using validated software. TFV was automatically 
calculated within the heart limits. Baseline and 4-year changes in EFV and TFV were compared between incCC+ and incCC- patients. Based on our 
published reports of reproducibility, EFV and TFV increase and decrease were defined by change ≥ 8% of baseline. 
Results:  Risk factor prevalences, weight, and body-mass-index were not different between incCC+ and incCC- patients. Baseline EFV and TFV 
were similar between the 2 groups (EFV, 81.1±37.3cm3 vs. 80.7±38.9 cm3, p=0.87; TFV, 157.9±72.9cm3 vs. 153.0±79.2 cm3, p=0.42). There 
was no baseline threshold above which EFV or TFV was associated with incCC+. Over 4 years, EFV increased in 58% of incCC+ and 62% of incCC- 
(p=0.57) and decreased in 10% of incCC+ and 13% of incCC- (p=0.52). Mean EFV change and TFV change between the 2 groups were similar (EFV, 
8.5±18.5cm3 in incCC+ vs. 10.0±19.9cm3 in incCC-, p=0.54; TFV, 14.3±38.6cm3 vs. 18.6±44.2 cm3, p=0.58), as were % EFV and TFV change, using 
baseline volume as reference (EFV, 13±21% vs. 15±23%, p=0.58; TFV, 12±21% vs. 15±25%, p=0.74). 
Conclusion: In a predominantly low-risk population with zero CCS, incident coronary calcification was not related to baseline EFV and TFV or serial 
changes in EFV and TFV. Further studies should be performed in higher risk populations.
